TipRanks
SAMSUNG PHARMACEUTICAL.CO.,Ltd. (KR:001360)
:001360
South Korea Market
001360
SAMSUNG PHARMACEUTICAL.CO.,Ltd.
RESEARCH TOOLSreports

SAMSUNG PHARMACEUTICAL.CO.,Ltd. (001360) Ratios

― Followers

SAMSUNG PHARMACEUTICAL.CO.,Ltd. Ratios

KR:001360's free cash flow for Q2 2026 was ₩0.32. For the 2026 fiscal year, KR:001360's free cash flow was decreased by ₩ and operating cash flow was ₩-0.50. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.77 0.92 2.53 2.30 4.89
Quick Ratio
 0.51 0.68 1.45 1.03 4.53
Cash Ratio
 0.11 0.26 0.40 0.33 2.53
Solvency Ratio
 -2.79 0.28 -0.53 -1.44 -1.44
Operating Cash Flow Ratio
 -0.22 -0.24 -0.93 -2.16 -0.13
Short-Term Operating Cash Flow Coverage
 -0.61 -0.58 -4.32 -56.02 -6.12
Net Current Asset Value
₩ -18.00B₩ -7.41B₩ 24.41B₩ 13.56B₩ 54.25B
Leverage Ratios
Debt-to-Assets Ratio
 0.15 0.11 0.04 <0.01 0.02
Debt-to-Equity Ratio
 0.26 0.15 0.05 <0.01 0.02
Debt-to-Capital Ratio
 0.20 0.13 0.05 <0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.05 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.68 1.38 1.21 1.20 1.15
Debt Service Coverage Ratio
 -0.94 -0.98 -2.77 -40.25 -51.87
Interest Coverage Ratio
 -6.76 -16.28 -64.18 -245.91 -125.67
Debt to Market Cap
 0.14 0.12 0.03 <0.01 <0.01
Interest Debt Per Share
 224.01 200.65 59.75 9.00 28.38
Net Debt to EBITDA
 -0.88 -0.36 0.19 0.17 1.55
Profitability Margins
Gross Profit Margin
38.51%31.78%44.64%44.22%47.50%
EBIT Margin
-39.32%-42.23%-31.29%-45.43%-48.20%
EBITDA Margin
-37.40%-39.21%-26.50%-41.74%-42.40%
Operating Profit Margin
-39.32%-42.23%-33.48%-34.73%-26.94%
Pretax Profit Margin
-320.93%25.06%-31.81%-45.57%-48.41%
Net Profit Margin
-320.93%25.06%-31.81%-47.76%-48.41%
Continuous Operations Profit Margin
-320.93%25.06%-31.81%-47.76%-48.41%
Net Income Per EBT
100.00%100.00%100.00%104.80%100.00%
EBT Per EBIT
816.12%-59.34%95.03%131.22%179.73%
Return on Assets (ROA)
-113.28%6.90%-10.97%-26.54%-21.28%
Return on Equity (ROE)
-109.02%9.54%-13.31%-31.98%-24.46%
Return on Capital Employed (ROCE)
-20.78%-15.55%-13.49%-22.37%-13.47%
Return on Invested Capital (ROIC)
-17.62%-13.63%-12.93%-22.10%-13.30%
Return on Tangible Assets
-130.41%7.62%-11.47%-28.25%-21.50%
Earnings Yield
-101.69%8.01%-10.16%-16.34%-12.70%
Efficiency Ratios
Receivables Turnover
 4.80 4.84 3.36 7.74 7.01
Payables Turnover
 6.73 7.23 5.61 4.95 5.76
Inventory Turnover
 2.55 3.07 1.22 1.78 5.41
Fixed Asset Turnover
 1.49 1.68 1.59 1.99 1.95
Asset Turnover
 0.35 0.28 0.34 0.56 0.44
Working Capital Turnover Ratio
 -7.96 3.67 1.97 1.44 0.84
Cash Conversion Cycle
 165.29 143.99 342.23 178.16 56.16
Days of Sales Outstanding
 76.10 75.47 108.60 47.18 52.05
Days of Inventory Outstanding
 143.40 119.00 298.70 204.76 67.51
Days of Payables Outstanding
 54.21 50.48 65.07 73.78 63.41
Operating Cycle
 219.50 194.47 407.30 251.94 119.57
Cash Flow Ratios
Operating Cash Flow Per Share
 -93.49 -106.74 -191.72 -372.11 -25.73
Free Cash Flow Per Share
 -103.61 -107.31 -195.94 -544.05 -66.53
CapEx Per Share
 143.20 0.57 4.22 171.94 40.79
Free Cash Flow to Operating Cash Flow
 1.11 1.01 1.02 1.46 2.59
Dividend Paid and CapEx Coverage Ratio
 -0.65 -186.61 -45.43 -2.16 -0.63
Capital Expenditure Coverage Ratio
 -0.65 -186.61 -45.43 -2.16 -0.63
Operating Cash Flow Coverage Ratio
 -0.47 -0.57 -3.35 -46.44 -0.96
Operating Cash Flow to Sales Ratio
 -0.21 -0.22 -0.39 -0.53 -0.04
Free Cash Flow Yield
-7.23%-7.01%-12.74%-26.62%-2.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.99 12.47 -9.85 -6.12 -7.87
Price-to-Sales (P/S) Ratio
 3.16 3.13 3.13 2.92 3.81
Price-to-Book (P/B) Ratio
 1.87 1.19 1.31 1.96 1.93
Price-to-Free Cash Flow (P/FCF) Ratio
 -13.83 -14.26 -7.85 -3.76 -39.91
Price-to-Operating Cash Flow Ratio
 -15.33 -14.33 -8.02 -5.49 -103.18
Price-to-Earnings Growth (PEG) Ratio
 -0.49 -0.07 0.19 5.95 0.20
Price-to-Fair Value
 1.87 1.19 1.31 1.96 1.93
Enterprise Value Multiple
 -9.32 -8.34 -11.63 -6.83 -7.44
Enterprise Value
 148.92B 150.60B 136.52B 148.20B 163.53B
EV to EBITDA
 -9.32 -8.34 -11.63 -6.83 -7.44
EV to Sales
 3.48 3.27 3.08 2.85 3.15
EV to Free Cash Flow
 -15.27 -14.90 -7.72 -3.67 -33.04
EV to Operating Cash Flow
 -16.92 -14.98 -7.89 -5.36 -85.43
Tangible Book Value Per Share
 598.85 1.12K 1.11K 967.89 1.36K
Shareholders’ Equity Per Share
 767.75 1.29K 1.17K 1.04K 1.38K
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 -0.05 0.00
Revenue Per Share
 454.05 489.31 491.01 699.02 696.74
Net Income Per Share
 -1.46K 122.61 -156.21 -333.83 -337.30
Tax Burden
 1.00 1.00 1.00 1.05 1.00
Interest Burden
 8.16 -0.59 1.02 1.00 1.00
Research & Development to Revenue
 0.08 0.08 0.03 0.04 <0.01
SG&A to Revenue
 0.67 0.54 0.57 0.64 0.63
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.06 -0.87 1.23 1.11 0.08
Currency in KRW